📌 Key Takeaways
- Topic: Silicon Dioxide CAS 7631-86-9: Identification, Properties and Regulatory Information
- Keywords: silica flatting agent
- Published: 2026-11-20 03:42:51
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Silicon Nitride vs Silicon Dioxide: Properties and Applications Compared
- Silica Supplier Thailand: Market Overview and Sourcing Options
- Angular Silica Powder: Properties, Uses and When to Choose It Over Spherical Silica
- Fumed Silica Alternatives: Cost-Effective Substitutes and How They Compare
- 38. Kheirkhah S., Abedi M., Zare F., Salmanpour M., Abolmaali S.S., Tamaddon A.M. Surface engineered palmitoyl-mesoporous silica nanoparticles with supported lipid bilayer coatings for high-capacity loading and prolonged release of dexamethasone: A factorial design approach. J. Drug Deliv. Sci. Technol. 2022;78:103943. doi: 10.1016/j.jddst.2022.103943. [ DOI ] [ Google Scholar ]
- Crystalline Silica Powder: Grades, Uses and Safe Handling Requirements
- In the case of melt granulation, it is necessary to use meltable excipients that can melt at low temperatures (50-90 °C) as a binder [ 98, 108 ]. The molten binder forms the agglomerates during cooling and solidification. Since it does not need a liquid binder, it is advantageous for use in the case of moisture-sensitive molecules. However, its use should be avoided for heat-sensitive materials.
Fumed Silica Manufacturer: Production Process, Key Grades and How to Choose
What is silica (SiO₂)?
what is silica 2. Effect of the Physicochemical Properties
What is the difference between fumed silica and precipitated silica?
silicon dioxide common name 1. Abeer M.M., Rewatkar P., Qu Z., Talekar M., Kleitz F., Schmid R., Lindén M., Kumeria T., Popat A. Silica nanoparticles: A promising platform for improved oral delivery of macromolecules. J. Control. Release. 2020;326:544-555. doi: 10.1016/j.jconrel.2020.07.021. [ DOI ] [ PubMed ] [ Google Scholar ]
What drives silica raw material prices?
silica flow agent In spite of the advantages of solvent-free processes, solvent-based techniques offer a more widespread choice for filling the pores of the carriers. Each method listed here consists of two steps. First, mixing the drug solution and carrier, then removing the solvent [ 36 ]. The loading cycles can be repeated as many times as desired to increase the charging efficiency [ 20, 36 ]. These techniques can be effectively applied to molecules both with great and poor aqueous solubility [ 37 ]. However, removing the solvent residue at the end of the process is essential, owing to the toxicity of usually used organic solvents [ 56 ], and it is normally better to select a less toxic organic solvent, if possible [ 37, 56 ]. The adsorption of the API is also influenced by the properties of the solvent, such as viscosity or surface tension. This group includes the adsorption approach, the incipient wetness approach, the solvent evaporation method, and the use of liquid and supercritical CO 2. The adsorption technique (solvent immersion method) is a low-energy process, but the pores can be filled effectively only if the API reaches a high concentration in the solvent [ 37 ]. The carrier system is immersed in the concentrated drug solution, while the liquid fills the pores owing to capillary forces. The mesopores are then separated from the solution by filtration or centrifugation. Finally, the pores are dried under reduced pressure [ 2, 36, 37 ]. Drug loading abilities can be seen for some APIs by this loading approach, in the following figure ( Figure 1 ). During the incipient wetness impregnation, a greatly concentrated drug solution is added dropwise onto the surface of the mesopores, in a nearly equal volume to the pore volume of the carrier [ 37 ]. In this case, the pores are filled with liquid also owing to the capillary forces. Then the pores are dried out at a higher temperature and under reduced pressure [ 2, 36, 37 ]. Nevertheless, the third approach, solvent evaporation, is the most widely used because it can be applied to a wide range of molecules, regardless of their solubility, making it fitting for higher therapeutic doses as well. It is not necessary to prepare a concentrated solution since the concentration gradually increases during the process (owing to the evaporation of the solvent). During the process, the drug should be dissolved in a volatile organic solvent, which is mixed with the carrier system [ 20 ]. All solvents are then eliminated by quick evaporation [ 37 ], while the drug is absorbed into the pores of the drug carrier [ 36, 37 ]. The use of supercritical CO 2 brings about more productive and deeper pore filling compared to other solvents. In this state, neither a liquid phase nor a gas phase exists. It combines the brilliant diffusion capacity of gases and the excellent solvation capacity of liquids. In addition, it is non-toxic, non-flammable, and can be readily eliminated from the system. A cost-effective choice can be liquid CO 2, which is a similarly effective solvent [ 36, 37 ].
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.